| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Stanton Marshall S. | SVP, Clinical & MD Affair | 1655 ROBERTS BLVD., NW, KENNESAW | /s/ Marshall Stanton | 28 Aug 2025 | 0001849615 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AORT | Common Stock | Options Exercise | $200,746 | +18,200 | +28% | $11.03 | 82,400 | 27 Aug 2025 | Direct | |
| transaction | AORT | Common Stock | Sale | $801,219 | -18,200 | -22% | $44.02 | 64,200 | 27 Aug 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AORT | Stock Option (Right to Buy) | Options Exercise | $0 | -18,200 | -100% | $0.000000 | 0 | 27 Aug 2025 | Common Stock | 18,200 | $11.03 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Reflects weighted average price. Range of prices were between $43.84 to $44.26. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F2 | Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was November 8, 2023. |